Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies-Reference-Cited by-同舟云学术

Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies

Published:2018-07-09 Issue:4 Volume:21 Page:539-548
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Sfanos Karen S.^ORCID,Markowski Mark C.,Peiffer Lauren B.,Ernst Sarah E.,White James R.,Pienta Kenneth J.^ORCID,Antonarakis Emmanuel S.,Ross Ashley E.

Funder

Prostate Cancer Foundation

U.S. Department of Defense

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/s41391-018-0061-x.pdf

Reference33 articles.

1. Spanogiannopoulos P, Bess EN, Carmody RN, Turnbaugh PJ. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol. 2016;14:273–87.

2. Vande Voorde J, Sabuncuoğlu S, Noppen S, Hofer A, Ranjbarian F, Fieuws S, et al. Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine. J Biol Chem. 2014;289:13054–65.

3. Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357:1156–60.

4. Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science. 2010;330:831–5.

5. Vétizou M, Pitt JM, Daillère R, Lepage P, Waldschmitt N, Flament C, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350:1079–84.

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural characteristics and intestinal flora metabolism mediated immunoregulatory effects of Lactarius deliciosus polysaccharide;International Journal of Biological Macromolecules;2024-10

2. A cross‐species analysis of fecal microbiomes in humans and mice reveals similarities and dissimilarities associated with prostate cancer risk;The Prostate;2024-08-07

3. Gut microbiome: a novel preventive and therapeutic target for prostatic disease;Frontiers in Cellular and Infection Microbiology;2024-07-29

4. Clinical Applications of the Gut Microbiome in Genitourinary Cancers;American Society of Clinical Oncology Educational Book;2024-06

5. Metabolic Response to Androgen Deprivation Therapy of Prostate Cancer;Cancers;2024-05-24